GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Mar 14, 2022 · 10-K · 73 days after period end · 0001818331-22-000037
| Metric | Q4 2021 | Q4 2020 |
|---|---|---|
| Revenue | $57.80M | $63.96M |
| Net Income | -$40.19M | -$125.68M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 14, 2022 · 73 d after period end
